EVERSEPT PARTNERS, LP – United Therapeutics Corporation Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$53.43M
portfolio value
EVERSEPT PARTNERS, LP quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -17.89% | -55.60K shares | -19.80M | $209.38 | 255.22K |
| Q2 2022 | share | Increase | +6.36% | 18.6K shares | 20.81M | $235.64 | 310.83K |
| Q1 2022 | share | Decrease | -25.44% | -99.68K shares | -32.25M | $179.41 | 292.23K |
| Q4 2021 | share | Decrease | -11.82% | -52.55K shares | 2.64M | $215.18 | 391.92K |
| Q3 2021 | share | Increase | +0.34% | 1.52K shares | 2.57M | $184.58 | 444.47K |
| Q2 2021 | share | Decrease | -8.96% | -43.58K shares | -1.91M | $179.41 | 442.94K |
| Q1 2021 | share | Increase | +6.08% | 27.89K shares | 11.76M | $167.27 | 486.52K |
| Q4 2020 | share | Increase | +90.38% | 217.73K shares | 45.28M | $151.79 | 458.63K |
| Q3 2020 | share | Increase | +3.54% | 8.22K shares | -3.82M | $101 | 240.90K |
| Q2 2020 | share | Increase | 0.00% | 232.67K shares | 28.15M | $121 | 232.67K |